An observational study in Cerebrovascular Disorders, sponsored by National and Kapodistrian University of Athens. Completed at 10 sites in Greece. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-04-13.
Sponsored by National and Kapodistrian University of Athens · Observational
The main objectives of the proposed project are:
A prospective cohort multicenter study of patients with first ever acute stroke, hemorrhagic and ischemic, (ICD-10 codes: I61, I63 and I64) admitted within 48 hours of symptoms onset to seven NHS and University hospitals will be conducted. About 1,000 patients (2% of all new cases/annually) will be recruited from six urban and semi-urban areas with 5.5 mil people (50% of Greek population), reporting 25,000 discharged stroke cases annually (53% of all stroke discharges), according to data derived from Hellenic Statistical Authority. All patients will be followed for three months. Moreover, a sub-group of the 300 firstly recruited patients will be followed for a year to obtain data on post hospital health and social needs, health services utilization (medication, rehabilitation, outpatient visits) and productivity loss . Patient enrolment and follow up is estimated to last 18 months.
7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.
This study's enrollment of 913 is above the median of 160 across 1,692 observational studies indexed under Stroke.
Browse Stroke studies →National and Kapodistrian University of Athens is the lead sponsor of 168 studies on the registry; 50 are open to participants now.
Counted across the registry records on this site, refreshed daily.
About 1,000 first ever stroke patients (2% of all new cases/annually) will be recruited from six urban and semi-urban areas with 5.5 mil people (50% of Greek population), reporting 25,000 discharged stroke cases annually. All patients will be followed for three months.
Inclusion Criteria:
Mortality
Patient based stroke (inpatient and outpatient) mortality
Time frame: Through hospitalization completion, an average of 10 days
Mortality
Patient based stroke (inpatient and outpatient) mortality
Time frame: One month
Mortality
Patient based stroke (inpatient and outpatient) mortality
Time frame: Three months
Modified Rankin Scale (mRS) score
mRS measures the degree of disability or dependence in the daily activities of patients after a stroke or other causes of neurological disability (0: no symptoms at all - 6: Dead)
Time frame: Through hospitalization completion, an average of 10 days
Modified Rankin Scale (mRS) score
mRS measures the degree of disability or dependence in the daily activities of patients after a stroke or other causes of neurological disability (0: no symptoms at all - 6: Dead)
Time frame: One month
Modified Rankin Scale (mRS) score
mRS measures the degree of disability or dependence in the daily activities of patients after a stroke or other causes of neurological disability (0: no symptoms at all - 6: Dead)
Time frame: Three months
National Institutes of Health Stroke Scale (NIHSS) score
NIHSS is a method for assessing the severity of a stroke experienced by a patient (0: No Stroke Symptoms, 42:Severe Stroke)
Time frame: Through hospitalization completion, an average of 10 days
National Institutes of Health Stroke Scale (NIHSS) score
NIHSS is a method for assessing the severity of a stroke experienced by a patient (0: No Stroke Symptoms, 42: Severe Stroke)
Time frame: One month
National Institutes of Health Stroke Scale (NIHSS) score
NIHSS is a method for assessing the severity of a stroke experienced by a patient (0: No Stroke Symptoms, 42: Severe Stroke)
Time frame: Three months
Cost
Average cost per patient
Time frame: Through hospitalization completion, an average of 10 days
Cost
Average cost per patient
Time frame: One month
Cost
Average cost per patient
Time frame: Three months
Plan to share: Undecided
This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National and Kapodistrian University of Athens